NMPA Approval

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)

Approval Number

J20171032

Registration Date

July 18, 2017

Drug Information

Generic Name

沙格列汀二甲双胍缓释片(Ⅲ)

Trade Name

安立格

Dosage Form

片剂

Strength

每片含沙格列汀2.5mg与盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

July 18, 2017

Company Address

SE-151 85 Sodertalje,Sweden

Company Address

4601 Hwy 62 East, Mount Vernon, Indiana 47620 USA

Empowering clinical research with data-driven insights and AI-powered tools.

沙格列汀二甲双胍缓释片(Ⅲ) - NMPA 批准文号 | MedPath